# Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation

Study · id `cardio:ct-nct03620760` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03620760](<https://clinicaltrials.gov/study/NCT03620760>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03620760

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2036 participants.

## Technical summary

Registry record NCT03620760. Randomized; no masking; primary purpose treatment. Start 2018-08-07 (actual); primary completion 2020-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2036 participants (planned count; ClinicalTrials.gov record NCT03620760, source copy `cardio:ctgov-nct03620760-2018-12-24`, retrieved 2026-10-26)
- Started: 2018-08-07 (actual) (ClinicalTrials.gov record NCT03620760, source copy `cardio:ctgov-nct03620760-2018-12-24`, retrieved 2026-10-26)
- Primary completion: 2020-12-31 (anticipated) (ClinicalTrials.gov record NCT03620760, source copy `cardio:ctgov-nct03620760-2018-12-24`, retrieved 2026-10-26)
- Completion: 2020-12-31 (anticipated) (ClinicalTrials.gov record NCT03620760, source copy `cardio:ctgov-nct03620760-2018-12-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03620760, source copy `cardio:ctgov-nct03620760-2018-12-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03620760-2018-12-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation
- Condition: Unstable Angina Pectoris
- Condition: Coronary Stent Implantation
- Intervention (Drug): Ticagrelor 90 mg
- Intervention (Drug): Ticagrelor 45 mg
- Intervention (Drug): Aspirin
- Lead sponsor: Xiaofan Wu
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)

## Provenance

Content hash: f44b7fe29b014ee37c695b5e3afa9b65d58018859ee1dc669d1fc9948f0b0b7b
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
